Last deal

$250K

Amount

Grant

Stage

07.03.2024

Date

3

all rounds

$425K

Total amount

date founded

Financing round

General

About Company
NeuroAge Therapeutics is a longevity biotech firm that develops new medications to regenerate biological brain aging.

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

NeuroAge Therapeutics is a longevity biotech firm that develops new medications to rejuvenate biological brain aging and treat neurodegenerative illnesses utilizing a machine learning aging clock technology.
Contacts

Social url

Financials

Funding Rounds
3
3

Number of Funding Rounds

$425K

Money Raised

Their latest funding was raised on 07.03.2024. Their latest investor Alzheimer's Drug Discovery Foundation. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
22.02.2023
$99K
13.08.2022
$76K
Alzheimer's Drug Discovery Foundation

Alzheimer's Drug Discovery Foundation

The Alzheimer’s Drug Discovery Foundation finds drugs for Alzheimer’s disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

count Of Investments

35

count Of Exists

1
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Alzheimer's Drug Discovery Foundation

Alzheimer's Drug Discovery Foundation

The Alzheimer’s Drug Discovery Foundation finds drugs for Alzheimer’s disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

count Of Investments

35

count Of Exists

1

Activity

Recent News
0